Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic-induced gut microbiota knockdown in overweight insulin-resistant men
NL-OMON39276Active, not recruiting
- Sponsor
- Maastricht University
- Start
- May 2012
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in obesity, prediabetes and insulin resistance (IR) comparing Vancomycin, Amoxicillin and Placebo (3 arms). Primary endpoint: Insulin sensitivity. Started May 2012; status: active, not recruiting.
02
Drugs
vancomycinamoxicillin
03
Conditions
obesityprediabetesinsulin resistance (IR)
Beyond the preview
Go deeper on NL-OMON39276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39276.